Items of Interest
Icon Key
 |
Stay Informed |
 |
Know Your Benefits |
 |
Get Involved |
 |
Community Corner |
 |
Be Healthy |
|
|
Pfizer News
Topline Results From Phase 3 Trial of Sunitinib With Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC)
World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children
Pfizer Receives FDA Approval for Prefilled Dual-Chamber Syringe for Use in the Treatment of Hemophilia A
Pfizer Reports Second-Quarter 2010 Results
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
EISAI INC. AND PFIZER INC ANNOUNCE U.S. FDA APPROVAL FOR NEW HIGHER-DOSE ARICEPT® (DONEPEZIL HCL) 23 MG TABLET FOR THE TREATMENT OF MODERATE-TO-SEVERE ALZHEIMER’S DISEASE
Pfizer to Offer Free Public Access to Mental Health Assessment Tools to Improve Diagnosis and Patient Care
Pfizer to Present More Than 40 Abstracts on Pre-Clinical, Clinical and Outcomes Research at Alzheimer's Association International Conference on Alzheimer's Disease
Read more Pfizer news
|
You may hear about recently announced benefit changes that affect our active Pfizer colleagues. These changes do not affect benefits of current retirees. There will be changes to retiree benefits that go into effect on January 1, 2011, including enhancements required as a result of the recently passed U.S. healthcare legislation. More information will be sent to you in the fall.
|
|